UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 207

Sortiert nach

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Chest, 2018-11, Vol.154 (5), p.1061-1069

2018

Volltextzugriff (PDF)

Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction

American journal of respiratory and critical care medicine, 2014-01, Vol.189 (2), p.159-166

2014

Volltextzugriff (PDF)

Pretransplant physical frailty, postoperative delirium, and short-term outcomes among older lung transplant recipients

Experimental gerontology, 2022-06, Vol.163, p.111781-111781, Article 111781

2022

Volltextzugriff (PDF)

Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation

Psychosomatic medicine, 2018-05, Vol.80 (4), p.403

2018

Volltextzugriff (PDF)

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

The European respiratory journal, 2014-07, Vol.44 (1), p.178-187

2014

Volltextzugriff (PDF)

The utility of preoperative six-minute-walk distance in lung transplantation

American journal of respiratory and critical care medicine, 2015-10, Vol.192 (7), p.843-852

2015

Volltextzugriff (PDF)

Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation

American journal of respiratory and critical care medicine, 2010-06, Vol.181 (12), p.1391-1396

2010

Volltextzugriff (PDF)

Quantitative Proteomics of Bronchoalveolar Lavage Fluid in Idiopathic Pulmonary Fibrosis

Journal of proteome research, 2015-02, Vol.14 (2), p.1238-1249

2015

Volltextzugriff (PDF)

Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation

Chest, 2023-07, Vol.164 (1), p.159-168

2023

Volltextzugriff (PDF)

External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real World Data Sources

American journal of respiratory and critical care medicine, 2023-09, Vol.208 (5), p.579-588

2023

Volltextzugriff (PDF)

Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients

Chest, 2013-07, Vol.144 (1), p.226-233

2013

Volltextzugriff (PDF)

Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation

American journal of respiratory and critical care medicine, 2016-01, Vol.193 (1), p.78-85

2016

Volltextzugriff (PDF)

Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study

American journal of respiratory and critical care medicine, 2020-08, Vol.202 (4), p.576-585

2020

Volltextzugriff (PDF)

Erratum to Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. J Heart Lung Transpl 2022;41(10):1511-19. https://doi.org/10.1016/j.healun.2022.04.009

The Journal of heart and lung transplantation, 2023-05, Vol.42 (5), p.688-688

2023

Volltextzugriff (PDF)

Lung Transplantation and the Era of the Sensitized Patient

Frontiers in immunology, 2021-05, Vol.12, p.689420-689420

2021

Volltextzugriff (PDF)

Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction

The Journal of heart and lung transplantation, 2024-07

2024

Volltextzugriff (PDF)

Do donors matter? Short telomeres and survival after lung transplant

Thorax, 2017-11, Vol.72 (11), p.965

2017

Volltextzugriff (PDF)

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis

Clinical therapeutics, 2023-04, Vol.45 (4), p.306-315

2023

Volltextzugriff (PDF)

Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial

Respiratory research, 2020-03, Vol.21 (1), p.68-68, Article 68

2020

Volltextzugriff (PDF)

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials

The lancet respiratory medicine, 2015-05, Vol.3 (5), p.388-396

2015

Volltextzugriff (PDF)

Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases

Journal of medical virology, 2023-04, Vol.95 (4), p.e28724-n/a

2023

Volltextzugriff (PDF)

Sleep quality, depressive symptoms, and transplant outcomes: Follow-up analyses from the ADAPT prospective pilot study

General hospital psychiatry, 2021-09, Vol.72, p.53-58

2021

Volltextzugriff (PDF)

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry

Respiratory research, 2019-05, Vol.20 (1), p.105-105, Article 105

2019

Volltextzugriff (PDF)

Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant

American journal of respiratory and critical care medicine, 2018-01, Vol.197 (2), p.235-243

2018

Volltextzugriff (PDF)

The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation

American journal of respiratory and critical care medicine, 2024-01, Vol.209 (1), p.91

2024

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Aktive Filter

ThemaSurgery

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(207)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(104)
Humans
(85)
Male
(61)
Female
(56)
Middle Aged
(40)
Lung Transplantation
(32)
Respiratory System
(32)
Adult
(27)
Aged
(27)
General & Internal Medicine
(27)
Critical Care Medicine
(19)
Biological And Medical Sciences
(15)
Animals
(13)
Lung Diseases
(13)
Mortality
(13)
Patients
(13)
Risk Factors
(13)
Lung Transplant
(12)
Lung Transplantation - Adverse Effects
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction

Pretransplant physical frailty, postoperative delirium, and short-term outcomes among older lung transplant recipients

Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

The utility of preoperative six-minute-walk distance in lung transplantation

Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation

Quantitative Proteomics of Bronchoalveolar Lavage Fluid in Idiopathic Pulmonary Fibrosis

Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation

External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real World Data Sources

Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients

Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation

Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study

Erratum to Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. J Heart Lung Transpl 2022;41(10):1511-19. https://doi.org/10.1016/j.healun.2022.04.009

Lung Transplantation and the Era of the Sensitized Patient

Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction

Do donors matter? Short telomeres and survival after lung transplant

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis

Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials

Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases

Sleep quality, depressive symptoms, and transplant outcomes: Follow-up analyses from the ADAPT prospective pilot study

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry

Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant

The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation

Aktive Filter

Suchergebnisse filtern